Key PointsA newly dovish FED has opened the floodgates for budget increases across the economy, and this sector is starting the trend by adding jobs.More than adding jobs, the sector has added investor interest in stocks like Pfizer and, most specifically, in Align Technology.Analysts and markets are all over this stock, and even the CEO has bought up to $2 million in stock ahead of the next rally.5 stocks we like better than PfizerBecause the past few months in the stock market have been a wild emotional r ...